Press Release

PhRMA Welcomes Five New Member Companies

Alexion Pharmaceuticals, Inc., Jazz Pharmaceuticals plc and Teva Pharmaceutical Industries Ltd. Join PhRMA; AMAG Pharmaceuticals, Inc. and Horizon Pharma plc Become Full Members

PhRMA July 15, 2016

Washington, DC (July 15, 2016) – The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today three biopharmaceutical research companies joined the association as members and two transitioned from research associates to full members.

The new members are Alexion Pharmaceuticals, Inc., New Haven, Connecticut; Jazz Pharmaceuticals plc, Palo Alto, California; and Teva Pharmaceutical Industries Ltd, North Wales, Pennsylvania. AMAG Pharmaceuticals, Inc., Waltham, Massachusetts, and Horizon Pharma plc, Lake Forest, Illinois, transitioned from research associates to full members.

“On behalf of the PhRMA Board of Directors, I am proud to welcome these companies into our membership,” PhRMA chairman and Biogen CEO George A. Scangos said. “Together as an industry, we can continue our work on issues to advance biomedical innovation and improve patient care.”

PhRMA continues to grow its membership at a time when the U.S. health care system is evolving to embrace a strong commercial market and value-driven health care. These new members will be integral to PhRMA’s efforts to advocate for policy solutions focused on delivering innovative treatments to patients, including modernizing the drug discovery and development process; promoting value-driven health care; engaging and empowering consumers; and addressing market distortions.

“We are pleased to welcome these companies into our membership. Collectively, our members are at the forefront of the most exciting and innovative biopharmaceutical research taking place in the industry today,” said Stephen J. Ubl, president and CEO of PhRMA. “The addition of these biopharmaceutical research companies will help guide us as we advocate for patient-centric policies to enhance the private market and address costs holistically.” 

For more information on each of these companies visit:

Alexion Pharmaceuticals, Inc.: http://alexion.com/

AMAG Pharmaceuticals, Inc.: http://www.amagpharma.com/

Horizon Pharma plc: http://www.horizonpharma.com/

Jazz Pharmaceuticals plc: https://www.jazzpharma.com/

Teva Pharmaceutical Industries Ltd.: http://www.tevapharm.com/

PhRMA’s policy solutions for delivering innovative treatments to patients can be viewed online here: http://phrma.org/sites/default/files/policy-solutions.pdf.


About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.

Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.FromHopetoCures.org
www.Facebook.com/PhRMA
www.Twitter.com/PhRMA